These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20375660)

  • 1. Clinical worsening in trials of pulmonary arterial hypertension: results and implications.
    Galiè N; Simonneau G; Barst RJ; Badesch D; Rubin L
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S11-9. PubMed ID: 20375660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective on the optimal endpoints for pulmonary arterial hypertension trials.
    Rubin L; Simonneau G
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S43-6. PubMed ID: 20375664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endpoints in pulmonary arterial hypertension: the role of clinical worsening.
    Peacock A; Keogh A; Humbert M
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S1-9. PubMed ID: 20375659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of endpoints in the pediatric population: congenital heart disease and idiopathic pulmonary arterial hypertension.
    Haworth SG; Beghetti M
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S35-41. PubMed ID: 20375663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing effectiveness of pulmonary arterial hypertension therapies in daily practice.
    Sitbon O; Hoeper MM; Simonneau G
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S21-6. PubMed ID: 20375661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of endpoints in pulmonary arterial hypertension associated with connective tissue disease.
    Coghlan JG; Pope J; Denton CP
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S27-34. PubMed ID: 20375662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial designs in PAH: shifting from functional measurements to long-term clinical outcomes.
    Studer SM; Gilkin RJ
    Am J Manag Care; 2014 Mar; 20(6 Suppl):S115-22. PubMed ID: 24716456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Just Another Statistic".
    Machtay M; Glatstein E
    Oncologist; 1998; 3(3):III-IV. PubMed ID: 10388105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise as an end-point in pulmonary hypertension trials.
    McCullagh B; Girgis RE
    Int J Clin Pract Suppl; 2010 Jan; (165):4-6. PubMed ID: 19958394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of pulmonary arterial hypertension.
    Adamali H; Gaine SP; Rubin LJ
    Semin Respir Crit Care Med; 2009 Aug; 30(4):484-92. PubMed ID: 19634087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension.
    Galiè N; Seeger W; Naeije R; Simonneau G; Rubin LJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):81S-88S. PubMed ID: 15194183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome measures in pulmonary arterial hypertension associated with systemic sclerosis.
    Kowal-Bielecka O; Delcroix M; Vonk-Noordegraaf A; Hoeper MM; Naeije R
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v39-41. PubMed ID: 18784140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endpoints for assessing drug activity in clinical trials.
    Pazdur R
    Oncologist; 2008; 13 Suppl 2():19-21. PubMed ID: 18434634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary arterial hypertension: an overview.
    Klinger JR
    Semin Cardiothorac Vasc Anesth; 2007 Jun; 11(2):96-103. PubMed ID: 17536113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting of time-to-event end points and tracking of failures in randomized trials of radiotherapy with or without any concomitant anticancer agent for locally advanced head and neck cancer.
    Le Tourneau C; Michiels S; Gan HK; Siu LL
    J Clin Oncol; 2009 Dec; 27(35):5965-71. PubMed ID: 19805677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New and future therapies in pulmonary arterial hypertension.
    Bull TM
    Semin Respir Crit Care Med; 2005 Aug; 26(4):429-36. PubMed ID: 16121320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with pulmonary arterial hypertension in clinical trials: who are they?
    Hill NS; Preston IR; Roberts KE
    Proc Am Thorac Soc; 2008 Jul; 5(5):603-9. PubMed ID: 18625752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment.
    Distler O; Pignone A
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 4():iv22-5. PubMed ID: 16980719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?
    Peacock AJ; Naeije R; Galiè N; Rubin L
    Eur Respir J; 2009 Jul; 34(1):231-42. PubMed ID: 19567606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.